SciClone Pharmaceuticals

USA

SciClone Pharmaceuticals

950 Tower Lane Suite 900

Jon Saxe,
Independent Chairman of the Board
Friedhelm Blobel,
President, Chief Executive Officer, Director
Gary Titus,
Chief Financial Officer, Senior Vice President - Finance
Simon Li,
Director
Peter Barret,
Independent Director
Richard Hawkins,
Independent Director
Gregg Lapointe,
Independent Director
Ira Lawrence,
Independent Director

Кардиология, Онкология, Инфекционные болезни

Производство

Вирусный гепатит, Рак легкого, Гипертензивная (гипертоническая) болезнь

SCLN

464.7600

Вакцины, Приборы, Технологии, Фармацевтика, Химия